Randomized clinical trial of long-term outcome after resection of hepatitis C virus-related hepatocellular carcinoma by postoperative interferon therapy

British Journal of Surgery

Volumn 89, Issue 4, 2002, Pages 418-422

  Kubo, S ^a   Nishiguchi, S ^a   Hirohashi, K ^a   Tanaka, H ^a   Shuto, T ^a   Kinoshita, H ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; LYMPHOBLAST INTERFERON;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; FATIGUE; HEPATITIS C VIRUS; HUMAN; KIDNEY ABSCESS; LIVER CELL CARCINOMA; LIVER FUNCTION; LIVER RESECTION; LONG TERM CARE; MALE; OUTCOMES RESEARCH; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE; TREATMENT OUTCOME;

AGED; ANTIVIRAL AGENTS; CARCINOMA, HEPATOCELLULAR; FEMALE; FOLLOW-UP STUDIES; HEPATITIS C; HUMANS; INTERFERON-ALPHA; LIVER NEOPLASMS; MALE; NEOPLASM RECURRENCE, LOCAL; POSTOPERATIVE CARE; RECURRENCE; SERUM ALBUMIN; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0036271549     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0007-1323.2001.02054.x     Document Type: Article

References (20)

1. Effects of continuous hepatitis with persistent hepatitis C viremia on outcome after resection of hepatocellular carcinoma
2. Risk factors for recurrence after resection of hepatitis C virus-related hepatocellular carcinoma
3. Randomised trial of effects of interferon-α on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis
4. Effects of long-term postoperative interferon-α on intrahepatic recurrence after resection of hepatitis C virus-related hepatocellular carcinoma. A randomized, controlled trial
5. Prevention of hepatocellular carcinoma in patients with chronic active hepatitis C and cirrhosis
6. A comparison of the surgical results in patients with hepatitis B versus hepatitis C-related hepatocellular carcinoma
7. Transection of the oesophagus for bleeding oesophageal varices
8. Classification of chronic hepatitis: Diagnosis, grading and staging
9. Clinicopathological criteria for multicentricity of hepatocellular carcinoma and risk factors for such carcinogenesis
10. Relationship between multicentric occurrence of hepatocellular carcinoma and histology of noncancerous hepatic tissue in patients with chronic hepatitis C
11. Interferon therapy reduces the risk for hepatocellular carcinoma: National surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan
12. Histologic improvement of fibrosis in patients with hepatitis C who have sustained response to interferon therapy
13. Human lymphoblastoid interferon. In vitro and in vivo studies in hepatocellular carcinoma
14. The interferons. Mechanisms of action and clinical applications
15. Interferon alfa and β down-regulate the expression of basic fibroblast growth factor in human carcinomas
16. Interferon beta prevents recurrence of hepatocellular carcinoma after complete resection or ablation of the primary tumor. A prospective randomized study of hepatitis C virus-related liver cancer
17. Recombinant interferon-α in inoperable hepatocellular carcinoma: A randomized controlled trial
18. Prognosis of recurrent hepatocellular carcinoma: A 10-year surgical experience in Japan
19. Prognostic factors after recurrence of resected hepatocellular carcinoma associated with hepatitis C virus
20. Determinants of outcome of compensated hepatitis C virus-related cirrhosis